These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Calcium-acidic phospholipid-phosphate complexes in human hydroxyapatite-containing pathologic deposits. Boskey AL; Bullough PG; Vigorita V; Di Carlo E Am J Pathol; 1988 Oct; 133(1):22-9. PubMed ID: 3177599 [TBL] [Abstract][Full Text] [Related]
44. Ultrastructural study of the long-term development of two experimental cutaneous calcinoses (topical calciphylaxis and topical calcergy) in the rat. Boivin G; Walzer C; Baud CA Cell Tissue Res; 1987 Mar; 247(3):525-32. PubMed ID: 3568098 [TBL] [Abstract][Full Text] [Related]
46. Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis. Pachman LM; Boskey AL Curr Rheumatol Rep; 2006 Jun; 8(3):236-43. PubMed ID: 16901083 [TBL] [Abstract][Full Text] [Related]
47. Calcific periarthritis of the finger verified by X-ray diffraction of apatite. Weber M; Gerber H Clin Rheumatol; 1993 Mar; 12(1):95-9. PubMed ID: 8385591 [TBL] [Abstract][Full Text] [Related]
49. Effect of diphosphonates on hydroxyapatite formation induced by calcium-phospholipid-phosphate complexes. Boskey AL; Goldberg MR; Posner AS Calcif Tissue Int; 1979 Mar; 27(1):83-8. PubMed ID: 111792 [TBL] [Abstract][Full Text] [Related]
50. Comparison of the effects of ethane-1-hydroxy-1,1-diphosphonate and dichloromethylene diphosphonate upon periodontal bone resorption in rice rats (Oryzomys palustris). Leonard EP; Reese WV; Mandel EJ Arch Oral Biol; 1979; 24(9):707-8. PubMed ID: 161500 [No Abstract] [Full Text] [Related]
52. Physical and chemical analyses of the mineral substance during the development of two experimental cutaneous calcifications in rats: topical calciphylaxis and topical calcergy. Tochon-Danguy HJ; Boivin G; Geoffroy M; Walzer C; Baud CA Z Naturforsch C Biosci; 1983; 38(1-2):135-40. PubMed ID: 6303011 [TBL] [Abstract][Full Text] [Related]
53. Effectiveness of phosphocitrate and N-sulpho-2-amino tricarballylate, a new analogue of phosphocitrate, in blocking hydroxyapatite induced crystal growth and calcium accumulation by matrix vesicles. Shankar R; Brown MR; Wong LK; Sallis JD Experientia; 1984 Mar; 40(3):265-7. PubMed ID: 6321227 [TBL] [Abstract][Full Text] [Related]
54. Calcergy in murine progressive ankylosis. Krug HE; Mahowald ML Agents Actions; 1991 Sep; 34(1-2):261-3. PubMed ID: 1793042 [TBL] [Abstract][Full Text] [Related]
55. Hereditary joint disorder in progressive ankylosis (ank/ank) mice. II. Effect of high-dose hydrocortisone treatment on inflammation and intraarticular calcium hydroxyapatite deposits. Hakim FT; Brown KS; Oppenheim JJ Arthritis Rheum; 1986 Jan; 29(1):114-23. PubMed ID: 3004514 [TBL] [Abstract][Full Text] [Related]
56. The production of calcification in connective tissue and skeletal muscle using various chemical compounds. McClure J; Gardner DL Calcif Tissue Res; 1976 Dec; 22(2):129-35. PubMed ID: 1000349 [TBL] [Abstract][Full Text] [Related]
57. A study of calcergy in the rat induced by the implantation of polyurethane sponges soaked in lead acetate. Hirsch RS; McClure J; Vernon-Roberts B; Smith K Aust J Exp Biol Med Sci; 1985 Apr; 63 ( Pt 2)():249-60. PubMed ID: 3876094 [TBL] [Abstract][Full Text] [Related]
58. Disaggregation of hydroxyapatite crystals. Bisaz S; Felix R; Hansen NM; Fleisch H Biochim Biophys Acta; 1976 Dec; 451(2):560-6. PubMed ID: 187229 [TBL] [Abstract][Full Text] [Related]
59. Intraluminal calcium hydroxyapatite crystals in breast carcinoma: an ultrastructural study. Torell JA; Knight JP; Marcus PB Ultrastruct Pathol; 1984; 6(1):9-14. PubMed ID: 6328717 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of local calcergy by topical application of calciphylactic challengers. Selye H; Somogyi A; Mécs I Calcif Tissue Res; 1968 Jul; 2(1):67-76. PubMed ID: 5724874 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]